866-997-4948(US-Canada Toll Free)

Global Depression Drugs Market 2017 Industry Research Report

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 123 Pages

In the last several years, Global market of Depression Drugs developed rapidly, with an average growth rate of 2.88%. In 2016, Global Revenue of Depression Drugs is nearly 15 B USD.

This report studies Depression Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Depression Drugs in these regions, from 2012 to 2022 (forecast), like
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
SSRIs
SNRIs
Others

Split by applications, this report focuses on consumption, market share and growth rate of Depression Drugs in each application, can be divided into
Hospitals
Clinics
Others



Table of Contents

1 Depression Drugs Market Overview1
1.1 Product Overview and Scope of Depression Drugs1
1.2 Depression Drugs Segment by Types2
1.2.1 Global Production Market Share of Depression Drugs by Types in 20162
1.2.2 SSRIs3
1.2.3 SNRIs4
1.3 Depression Drugs Segment by Applications5
1.3.1 Depression Drugs Consumption Market Share by Applications in 20165
1.3.2 Hospitals6
1.3.3 Clinics7
1.4 Global Depression Drugs Market by Regions (2012-2022)8
1.4.1 Global Depression Drugs Market Comparison by Regions8
1.4.2 North America Depression Drugs Status and Prospect (2012-2022)9
1.4.3 Asia-Pacific Depression Drugs Status and Prospect (2012-2022)10
1.4.4 Europe Depression Drugs Status and Prospect (2012-2022)11
1.4.5 South America Depression Drugs Status and Prospect (2012-2022)12
1.4.6 Middle East and Africa Depression Drugs Status and Prospect (2012-2022)13
1.5 Global Depression Drugs Market Size (2012-2022)14
2 Global Depression Drugs Market Competition by Manufacturers/Brand15
2.1 Global Depression Drugs Revenue (M USD) and Share by Manufacturers (2015 and 2016)15
2.2 Global Depression Drugs Gross Margin by Manufacturers (2015 and 2016)18
2.3 Manufacturers Depression Drugs Headquarters and Established Date20
2.4 Depression Drugs Market Competitive Situation and Trends22
2.4.1 Depression Drugs Market Share (%) of Top 3 and Top 5 Manufacturers22
2.4.2 Mergers & Acquisitions, Expansion23
3 Global Depression Drugs Sales Revenue (M USD) by Regions (2012-2017)27
3.1 Global Depression Drugs Revenue (M USD) and Market Share (%) by Regions (2012-2017)27
3.2 Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)29
3.3 North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
3.4 Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
3.5 Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
3.6 South America Depression Drugs Revenue (M USD) and Gross Margin (2012-2017)31
3.7 Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)31
4 Global Depression Drugs Sales Revenue by Types32
4.1 Global Depression Drugs Revenue and Market Share (%) by Types (2012-2017)32
4.2 Global Depression Drugs Sales Growth by Type (2012-2017)34
5 Global Depression Drugs Market Analysis by Applications35
5.1 Global Depression Drugs Revenue and Market Share (%) by Applications (2012-2017)35
5.2 Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)37
6 Analysis of Depression Drugs Industry Key Manufacturers38
6.1 Intellipharmaceutics38
6.1.1 Company Profile38
6.1.2 Product Information39
6.1.3 Revenue, Cost, Gross, and Gross Margin39
6.2 Pfizer40
6.2.1 Company Profile40
6.2.2 Product Information41
6.2.3 Revenue, Cost, Gross, and Gross Margin41
6.3 Eli Lilly41
6.3.1 Company Profile41
6.3.2 Product Information42
6.3.3 Revenue, Cost, Gross, and Gross Margin42
6.4 Astrazeneca43
6.4.1 Company Profile43
6.4.2 Product Information44
6.4.3 Revenue, Cost, Gross, and Gross Margin44
6.5 Lundbeck44
6.5.1 Company Profile44
6.5.2 Product Information45
6.5.3 Revenue, Cost, Gross, and Gross Margin46
6.6 Allergan46
6.6.1 Company Profile46
6.6.2 Product Information47
6.6.3 Revenue, Cost, Gross, and Gross Margin47
6.7 GSK48
6.7.1 Company Profile48
6.7.2 Product Information49
6.7.3 Revenue, Cost, Gross, and Gross Margin49
6.8 Otsuka Pharmaceutical49
6.8.1 Company Profile49
6.8.2 Product Information50
6.8.3 Revenue, Cost, Gross, and Gross Margin50
6.9 Takeda51
6.9.1 Company Profile51
6.9.2 Product Information52
6.9.3 Revenue, Cost, Gross, and Gross Margin52
6.10 NHU Group53
6.10.1 Company Profile53
6.10.2 Product Information54
6.10.3 Revenue, Cost, Gross, and Gross Margin54
6.11 Shionogi55
6.11.1 Company Profile55
6.11.2 Product Information56
6.11.3 Revenue, Cost, Gross, and Gross Margin56
6.12 APOTEX57
6.12.1 Company Profile57
6.12.2 Product Information58
6.12.3 Revenue, Cost, Gross, and Gross Margin58
6.13 Kanghong Pharma59
6.13.1 Company Profile59
6.13.2 Product Information60
6.13.3 Revenue, Cost, Gross, and Gross Margin61
6.14 HUAHAI61
6.14.1 Company Profile61
6.14.2 Product Information63
6.14.3 Revenue, Cost, Gross, and Gross Margin63
7 Depression Drugs Manufacturing Cost Analysis64
7.1 Depression Drugs Key Raw Materials Analysis64
7.1.1 Key Raw Materials64
7.1.2 Key Suppliers of Raw Materials65
7.2 Proportion of Manufacturing Cost Structure67
7.2.1 Raw Materials67
7.2.2 Labor Cost67
7.2.3 Other Costs Analysis74
7.3 Manufacturing Process Analysis of Depression Drugs79
8 Industrial Chain, Sourcing Strategy and Downstream Buyers80
8.1 Depression Drugs Industrial Chain Analysis80
8.2 Upstream Raw Materials Sourcing80
8.3 Downstream Buyers81
9 Marketing Strategy Analysis, Distributors/Traders84
9.1 Marketing Channel84
9.1.1 Direct Marketing84
9.1.2 Indirect Marketing84
9.1.3 Marketing Channel Development Trend84
9.2 Market Positioning85
9.2.1 Pricing Strategy85
9.2.2 Brand Strategy86
9.2.3 Target Client87
9.3 Distributors/Traders List88
10 Market Effect Factors Analysis90
10.1 Technology Progress/Risk90
10.1.1 Substitutes Threat90
10.1.2 Technology Progress in Related Industry90
10.2 Consumer Needs/Customer Preference Change92
10.3 Economic/Political Environmental Change92
11 Global Depression Drugs Market Forecast (2017-2022)98
11.1 Global Depression Drugs Revenue (M USD) Forecast (2017-2022)98
11.2 Global Depression Drugs Revenue (M USD) Forecast by Regions (2017-2022)98
11.2.1 North America Depression Drugs Revenue (M USD) Forecast (2017-2022)101
11.2.2 Europe Depression Drugs Revenue (M USD) Forecast (2017-2022)102
11.2.3 Asia-Pacific Depression Drugs Revenue (M USD) Forecast (2017-2022)103
11.2.4 South America Depression Drugs Revenue (M USD) Forecast (2017-2022)104
11.2.5 Middle East and Africa Depression Drugs Revenue (M USD) Forecast (2017-2022)105
11.3 Global Depression Drugs Revenue by Type (2017-2022)105
11.4 Global Depression Drugs Revenue Forecast by Application (2017-2022)106
12 Research Findings and Conclusion108
13 Appendix109
Author List109
Disclosure Section110
Research Methodology110
Data Source111
China Disclaimer111


List of Table

List of Tables and Figures

Figure Picture of Depression Drugs1
Table Classification of Depression Drugs2
Figure Global Production Market Share of Depression Drugs by Types in 20163
Figure Product Picture of SSRIs3
Figure Product Picture of SNRIs4
Table Applications of Depression Drugs5
Figure Depression Drugs Consumption Market Share by Applications in 20166
Figure Hospitals6
Figure Clinics7
Figure Global Depression Drugs Market Share by Regions 20168
Figure North America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)9
Figure Asia-Pacific Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)10
Figure Europe Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)11
Figure South America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)12
Figure Middle East and Africa Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022)13
Figure Global Depression Drugs Revenue (M USD) Status and Outlook (2012-2022)14
Table Global Depression Drugs Revenue (M USD) by Manufacturers (2015 and 2016)15
Table Global Depression Drugs Revenue Share (%) by Manufacturers (2015 and 2016)15
Figure 2015 Global Depression Drugs Revenue Share (%) by Manufacturers17
Figure 2016 Global Depression Drugs Revenue Share (%) by Manufacturers18
Table Global Market Depression Drugs Gross Margin of Key Manufacturers (2015 and 2016)18
Figure Global Market Depression Drugs Gross Margin of Key Manufacturers in 201620
Table Manufacturers Depression Drugs Headquarters and Established Date20
Table Manufacturers Depression Drugs Brand and Sales Area21
Figure Depression Drugs Market Share (%) of Top 3 Manufacturers 201622
Figure Depression Drugs Market Share (%) of Top 5 Manufacturers 201623
Table Mergers & Acquisitions, Expansion23
Table Global Depression Drugs Revenue (M USD) by Regions (2012-2017)27
Table Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017)27
Figure Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017)28
Figure 2012 Global Depression Drugs Revenue Market Share (%) by Regions28
Figure 2016 Global Depression Drugs Revenue Market Share (%) by Regions29
Table Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)29
Table North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
Table Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
Table Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)30
Table South America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)31
Table Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017)31
Table Global Depression Drugs Revenue (M USD) by Types (2012-2017)32
Table Global Depression Drugs Revenue Share (%) by Types (2012-2017)32
Figure Revenue Share (%) of Depression Drugs by Types (2012-2017)33
Figure 2016 Revenue Market Share (%) of Depression Drugs by Types33
Figure Global Depression Drugs Sales Growth (%) by Type (2012-2017)34
Table Global Depression Drugs Revenue by Applications (2012-2017)35
Table Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017)35
Figure Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017)36
Figure Global Depression Drugs Revenue Market Share (%) by Applications in 201636
Table Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)37
Figure Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017)37
Table Intellipharmaceutics Company Profile38
Figure Depression Drugs Product Picture of Intellipharmaceutics39
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Intellipharmaceutics 2015-201639
Table Pfizer Company Profile40
Figure Depression Drugs Product Picture of Pfizer41
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Pfizer 2015-201641
Table Eli Lilly Company Profile41
Figure Depression Drugs Product Picture of Eli Lilly42
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2015-201642
Table Astrazeneca Company Profile43
Figure Depression Drugs Product Picture of Astrazeneca44
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Astrazeneca 2015-201644
Table Lundbeck Company Profile44
Figure Depression Drugs Product Picture of Lundbeck45
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Lundbeck 2015-201646
Table Allergan Company Profile46
Figure Depression Drugs Product Picture of Allergan47
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Allergan 2015-201647
Table GSK Company Profile48
Figure Depression Drugs Product Picture of GSK49
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of GSK 2015-201649
Table Otsuka Pharmaceutical Company Profile49
Figure Depression Drugs Product Picture of Otsuka Pharmaceutical50
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Otsuka Pharmaceutical 2015-201650
Table Takeda Company Profile51
Figure Depression Drugs Product Picture of Takeda52
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2015-201652
Table NHU Group Company Profile53
Figure Depression Drugs Product Picture of NHU Group54
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of NHU Group 2015-201654
Table Shionogi Company Profile55
Figure Depression Drugs Product Picture of Shionogi56
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Shionogi 2015-201656
Table APOTEX Company Profile57
Figure Depression Drugs Product Picture of APOTEX58
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of APOTEX 2015-201658
Table Kanghong Pharma Company Profile59
Figure Depression Drugs Product Picture of Kanghong Pharma60
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kanghong Pharma 2015-201661
Table HUAHAI Company Profile61
Figure Depression Drugs Product Picture of HUAHAI63
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of HUAHAI 2015-201663
Table Raw Material Suppliers Analysis and Picture64
Table Key Suppliers of Raw Materials65
Table Manufacturing Cost Structure of Depression Drugs67
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)68
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)68
Figure Cost of Employing a Factory Worker70
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe71
Figure Monthly Minimum Wages in Asia 201672
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)73
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)73
Table Average Price of Electricity to Ultimate Customers74
Figure Electricity Prices for Household Consumers in 201675
Figure Summary of the Driving Assumptions76
Figure Industrial Electric Rates 2016 (PER KWH)77
Figure Manufacturing Process Analysis of Depression Drugs79
Figure Depression Drugs Industrial Chain Analysis80
Table Major Buyers of Depression Drugs81
Figure Setting Pricing Policy85
Table Distributors/Traders List88
Figure Global GDP Map 201693
Figure EU GDP Change 2006-201693
Figure German CPI Change 2016-201794
Figure UK CPI Change 2007-201694
Figure Japan GDP Change 2014-201795
Figure Japan CPI Change in 201695
Figure China GDP Change 2014-201795
Figure China CPI Change 2016-201796
Figure US GDP Change 2013-201696
Figure US CPI Change 2016-201797
Figure Global Depression Drugs Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)98
Table Global Depression Drugs Revenue Forecast by Regions (2017-2022)98
Table Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022)99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022)99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions 2022100
Figure North America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)101
Figure Europe Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)102
Figure Asia-Pacific Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)103
Figure South America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)104
Figure Middle East and Africa Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022)105
Table Global Depression Drugs Revenue (M USD) Forecast by Type (2017-2022)105
Table Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022)105
Figure Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022)106
Table Global Depression Drugs Revenue Forecast by Application (2017-2022)106
Figure Global Depression Drugs Sales Forecast by Application (2017-2022)107

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *